Damage to the genetic material of mitochondria – the mitochondrial DNA or mtDNA for short – can lead to diseases such as Parkinson's, Alzheimer's, amyotrophic lateral sclerosis (ALS), cardiovascular ...

An American neurologist and an Italian epidemiologist whose work revolutionized the treatment of multiple sclerosis on ...

Edaravone may exert its neuroprotective effects in ALS by also correcting the abnormal localization of TDP-43, a key ...

Damage to the mitochondria, the “power plants” of the cells, contributes to many diseases. Researchers from Heinrich Heine ...

Statin use does not affect survival outcomes for ALS patients, so there may be no need to stop taking them after a diagnosis, ...

Neurizon Therapeutics Limited (“Neurizon”), a clinical-stage biotech company dedicated to advancing treatments for ...

During the event held by the China Organ Donation Administrative Center in Shenyang, Liaoning province, Zhang was also ...

Tenvie Therapeutics Inc. has divulged NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors reported to be useful for the treatment of glaucoma, spinal cord injury, multiple sclerosis, Niemann-Pick ...

Pilar Viladas, a bonafide architecture writer and editor, and former AN Best of Design juror, died on March 15 at a ...

A research group led by Gian Gaetano Tartaglia, Principal Investigator at the Italian Institute of Technology (IIT), ...

THE COURAGE-ALS clinical trial, evaluating the efficacy of reldesemtiv in slowing disease progression in amyotrophic lateral ...

By joining the Stogner Strong Team, you'll be part of a movement dedicated to raising awareness and critical funds for ALS research, patient care, and support services. To learn more about ALS and ALS ...